Bortezomib Injection IP 3.5mg is a prescription medication used primarily in the treatment of certain types of cancers, particularly blood-related malignancies.

Description:
Active Ingredient: Bortezomib (3.5mg).
Class: Proteasome inhibitor.
Form: Lyophilized powder for reconstitution and intravenous (IV) or subcutaneous (SC) administration.
Mechanism of Action:
Inhibits the activity of proteasomes, cellular complexes that degrade unneeded or damaged proteins.
Disruption of proteasome activity leads to cell cycle arrest and apoptosis (programmed cell death), particularly in rapidly dividing cancer cells.
Uses:
Multiple Myeloma:
Used alone or in combination with other medications to treat newly diagnosed or relapsed cases.
Mantle Cell Lymphoma (MCL):
Used for the treatment of MCL in patients who have received at least one prior therapy.

Very secured payment methods
Shipping will be calculated on checkout
Please note that price may increase due to exchange rate, ensure updated price before making payment